PER percheron therapeutics limited

The article you so valiantly referred to is an old article with...

  1. 188 Posts.
    lightbulb Created with Sketch. 89
    The article you so valiantly referred to is an old article with old news. Refer to the AGILE Study which was published late December 2024 (not your article of 2022). Paxalisib showed efficacy and confirmed initial Ph I/II results which indicates a better SOC that the current drug Temazolomide that treats GBM.

    The drug works, Management did not work! I posted a long article on JG last night one here. Unfortunately, it was pulled. DYOR.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.